Roche Can Launch Mircera 10 Months Before Amgen's EPO Patent Expires

Amgen inked a license agreement with Roche in settling its patent infringement suit.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet